Immune regulation by fibroblasts in tissue injury depends on uPARAP-mediated uptake of collectins.


Journal

The Journal of cell biology
ISSN: 1540-8140
Titre abrégé: J Cell Biol
Pays: United States
ID NLM: 0375356

Informations de publication

Date de publication:
07 01 2019
Historique:
received: 07 03 2018
revised: 14 09 2018
accepted: 17 10 2018
pubmed: 28 10 2018
medline: 23 10 2019
entrez: 28 10 2018
Statut: ppublish

Résumé

Collectins such as mannose-binding lectin (MBL) and surfactant protein D (SP-D) become temporarily deposited in extravascular compartments after tissue injury and perform immune-stimulatory or inflammation-limiting functions. However, their turnover mechanisms, necessary to prevent excessive tissue damage, are virtually unknown. In this study, we show that fibroblasts in injured tissues undertake the clearance of collectins by using the endocytic collagen receptor uPARAP. In cellular assays, several types of collectins were endocytosed in a highly specific uPARAP-dependent process, not shared by the closely related receptor MR/CD206. When introduced into dermis or bleomycin-injured lungs of mice, collectins MBL and SP-D were endocytosed and routed for lysosomal degradation by uPARAP-positive fibroblasts. Fibroblast-specific expression of uPARAP governed endogenous SP-D levels and overall survival after lung injury. In lung tissue from idiopathic pulmonary fibrosis patients, a strong up-regulation of uPARAP was observed in fibroblasts adjacent to regions with SP-D secretion. This study demonstrates a novel immune-regulatory function of fibroblasts and identifies uPARAP as an endocytic receptor in immunity.

Identifiants

pubmed: 30366943
pii: jcb.201802148
doi: 10.1083/jcb.201802148
pmc: PMC6314555
doi:

Substances chimiques

IL6 protein, human 0
Interleukin-6 0
Lectins, C-Type 0
MRC2 protein, human 0
Mannose Receptor 0
Mannose-Binding Lectin 0
Mannose-Binding Lectins 0
Membrane Glycoproteins 0
Pulmonary Surfactant-Associated Protein D 0
Receptors, Cell Surface 0
Bleomycin 11056-06-7

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

333-349

Subventions

Organisme : Intramural NIH HHS
ID : ZIC DE000729
Pays : United States

Informations de copyright

© 2018 Jürgensen et al.

Références

Nat Rev Immunol. 2003 Feb;3(2):169-76
pubmed: 12563300
J Cell Biol. 2003 Mar 31;160(7):1009-15
pubmed: 12668656
J Biol Chem. 1996 Aug 30;271(35):21323-30
pubmed: 8702911
Hum Immunol. 2014 Jul;75(7):629-32
pubmed: 24798938
J Clin Invest. 2001 Feb;107(4):467-75
pubmed: 11181646
Am J Transplant. 2012 Apr;12(4):877-87
pubmed: 22225993
Science. 2002 Mar 8;295(5561):1898-901
pubmed: 11884756
BMC Pulm Med. 2014 Dec 08;14:196
pubmed: 25488319
Biochim Biophys Acta. 2002 Sep 19;1572(2-3):364-86
pubmed: 12223280
Chest. 2009 Aug;136(2):571-577
pubmed: 19666756
Am J Respir Cell Mol Biol. 2012 Feb;46(2):233-9
pubmed: 21940816
PLoS One. 2013 Aug 05;8(8):e71261
pubmed: 23940733
Am J Physiol Lung Cell Mol Physiol. 2001 Jul;281(1):L268-77
pubmed: 11404270
Hepatology. 2007 Jun;45(6):1454-61
pubmed: 17518370
Mol Cell Biol. 2007 Sep;27(18):6309-22
pubmed: 17620416
J Cell Sci. 2000 Mar;113 ( Pt 6):1021-32
pubmed: 10683150
Bone. 2014 Oct;67:181-8
pubmed: 25019594
J Exp Med. 2000 Dec 18;192(12):1797-808
pubmed: 11120776
J Biol Chem. 2000 Jan 21;275(3):1993-2002
pubmed: 10636902
J Biol Chem. 1997 May 23;272(21):13743-9
pubmed: 9153228
Innate Immun. 2010 Jun;16(3):191-200
pubmed: 20529971
J Allergy Clin Immunol. 2008 Nov;122(5):861-79; quiz 880-1
pubmed: 19000577
J Immunol. 2005 Jul 1;175(1):541-6
pubmed: 15972690
Int J Cancer. 2002 Apr 10;98(5):656-64
pubmed: 11920633
J Biol Chem. 2011 Jul 29;286(30):26996-7010
pubmed: 21652704
J Histochem Cytochem. 2007 Apr;55(4):347-53
pubmed: 17189524
Lab Invest. 2001 Oct;81(10):1403-14
pubmed: 11598153
J Biol Chem. 2011 Sep 16;286(37):32736-48
pubmed: 21768090
Cell. 2003 Oct 3;115(1):13-23
pubmed: 14531999
Trends Immunol. 2002 Nov;23(11):549-55
pubmed: 12401408
J Immunol. 2006 Feb 1;176(3):1769-75
pubmed: 16424207
J Leukoc Biol. 2012 Dec;92(6):1177-86
pubmed: 22966131
J Immunol. 2013 Aug 1;191(3):1021-8
pubmed: 23817419
Trends Microbiol. 2015 Dec;23(12):799-811
pubmed: 26482345
J Pathol. 2012 May;227(1):94-105
pubmed: 22294280
J Clin Invest. 2014 Jun;124(6):2348-54
pubmed: 24892709
J Clin Invest. 2003 May;111(10):1589-602
pubmed: 12750409
Am J Respir Crit Care Med. 2012 Mar 1;185(5):525-36
pubmed: 22198976
J Clin Invest. 2016 May 2;126(5):1911-25
pubmed: 27088797
Arch Dermatol Res. 2011 Sep;303(7):521-5
pubmed: 21327568
J Clin Invest. 2002 Mar;109(6):707-12
pubmed: 11901176
J Biol Chem. 2014 Mar 14;289(11):7935-47
pubmed: 24500714
J Invest Dermatol. 2005 Jul;125(1):166-73
pubmed: 15982317
Exp Lung Res. 2015 Mar;41(2):57-73
pubmed: 25514507
Am J Respir Cell Mol Biol. 2013 Oct;49(4):503-10
pubmed: 23672262
Exp Cell Res. 2004 Feb 1;293(1):106-16
pubmed: 14729061
Front Pharmacol. 2014 May 27;5:123
pubmed: 24904424
FEBS Lett. 1993 Dec 28;336(3):394-6
pubmed: 7904248
J Biol Chem. 2007 Sep 14;282(37):27037-45
pubmed: 17623673
Gene Expr. 1999;8(3):151-63
pubmed: 10634317
J Exp Med. 2008 Feb 18;205(2):331-7
pubmed: 18250193
Nature. 1995 May 11;375(6527):151-5
pubmed: 7753172
J Exp Med. 2012 May 7;209(5):925-33
pubmed: 22493518
Clin Exp Allergy. 2010 Apr;40(4):547-62
pubmed: 20447075
J Cell Biol. 2013 Sep 16;202(6):951-66
pubmed: 24019537
Am J Respir Crit Care Med. 2005 Oct 1;172(7):869-77
pubmed: 15994463
J Immunol. 2000 Jun 1;164(11):5866-70
pubmed: 10820266
J Leukoc Biol. 2014 Jul;96(1):105-11
pubmed: 24585933
Am J Physiol Lung Cell Mol Physiol. 2001 Mar;280(3):L379-86
pubmed: 11159019
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10649-54
pubmed: 27601670
Sci Rep. 2017 Jan 31;7:41770
pubmed: 28139758
Biochemistry. 2000 Jan 25;39(3):508-15
pubmed: 10642175
Clin Mol Allergy. 2010 Mar 25;8:6
pubmed: 20338057

Auteurs

Henrik J Jürgensen (HJ)

Finsen Laboratory, Rigshospitalet/Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Proteases and Tissue Remodeling Section, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.

Kirstine S Nørregaard (KS)

Finsen Laboratory, Rigshospitalet/Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.

Megan M Sibree (MM)

Proteases and Tissue Remodeling Section, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.

Eric Santoni-Rugiu (E)

Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Daniel H Madsen (DH)

Finsen Laboratory, Rigshospitalet/Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.
Center for Cancer Immune Therapy, Department of Haematology, Copenhagen University Hospital, Herlev, Denmark.
Proteases and Tissue Remodeling Section, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.

Katharina Wassilew (K)

Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Dorrit Krustrup (D)

Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Peter Garred (P)

Laboratory of Molecular Medicine, Department of Clinical Immunology Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Thomas H Bugge (TH)

Proteases and Tissue Remodeling Section, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.

Lars H Engelholm (LH)

Finsen Laboratory, Rigshospitalet/Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark.

Niels Behrendt (N)

Finsen Laboratory, Rigshospitalet/Biotech Research and Innovation Centre, University of Copenhagen, Copenhagen, Denmark niels.behrendt@finsenlab.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH